Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-04-03 Sale | 2023-04-04 8:51 pm | Neoleukin Therapeutics Inc. | NLTX | Patel Priti Former Chief Medical Officer | 3,769 | $0.6919 | $2,608 | 37,313 (Direct) | View |
| 2023-02-02 Sale | 2023-02-03 4:33 pm | Neoleukin Therapeutics Inc. | NLTX | Smith Sean Michael Principal Accounting Officer | 3,316 | $0.5972 | $1,980 | 28,460 (Direct) | View |
| 2023-02-02 Sale | 2023-02-03 4:32 pm | Neoleukin Therapeutics Inc. | NLTX | Patel Priti Chief Medical Officer | 14,380 | $0.5972 | $8,588 | 66,082 (Direct) | View |
| 2022-08-10 Sale | 2022-08-12 5:24 pm | Neoleukin Therapeutics Inc. | NLTX | Smith Sean Michael Principal Accounting Officer | 1,655 | $0.9914 | $1,641 | 11,776 (Direct) | View |
| 2022-05-02 Sale | 2022-05-03 7:16 pm | Neoleukin Therapeutics Inc. | NLTX | Patel Priti Chief Medical Officer | 5,538 | $1.2186 | $6,749 | 16,462 (Direct) | View |
| 2021-08-24 Purchase | 2021-08-26 7:08 pm | Neoleukin Therapeutics Inc. | NLTX | DRACHMAN JONATHAN G President and CEO | 150,000 | $6.2237 | $933,550 | 2,373,686 (Indirect Direct) | View |
| 2021-06-16 Sale | 2021-06-17 9:46 pm | Neoleukin Therapeutics Inc. | NLTX | Walkey Carl Senior Vice President | 600 | $10.19 | $6,114 | 1,352,489 (Direct) | View |
| 2021-06-09 Sale | 2021-06-11 4:13 pm | Neoleukin Therapeutics Inc. | NLTX | Walkey Carl Senior Vice President | 650 | $10.82 | $7,036 | 1,353,089 (Direct) | View |
| 2021-06-08 Sale | 2021-06-09 5:22 pm | Neoleukin Therapeutics Inc. | NLTX | Walkey Carl Senior Vice President | 600 | $11 | $6,600 | 1,353,739 (Direct) | View |
| 2021-06-04 Sale | 2021-06-07 5:07 pm | Neoleukin Therapeutics Inc. | NLTX | Walkey Carl Senior Vice President | 600 | $10 | $6,000 | 1,354,339 (Direct) | View |
| 2021-06-03 Purchase | 2021-06-07 5:06 pm | Neoleukin Therapeutics Inc. | NLTX | DRACHMAN JONATHAN G President and CEO | 50,000 | $9.5071 | $475,354 | 2,248,686 (Direct) | View |
| 2021-05-26 Sale | 2021-05-26 7:37 pm | Neoleukin Therapeutics Inc. | NLTX | Walkey Carl Senior Vice President | 600 | $10 | $6,000 | 1,354,939 (Direct) | View |
| 2021-05-19 Sale | 2021-05-21 5:24 pm | Neoleukin Therapeutics Inc. | NLTX | Walkey Carl Senior Vice President | 600 | $10.63 | $6,378 | 1,355,539 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-31 Exercise | 2023-04-04 8:51 pm | N/A N/A | Neoleukin Therapeutics Inc. | NLTX | Patel Priti Former Chief Medical Officer | 10,000 | $0 | 37,313 (Direct) | View |
| 2023-02-01 Exercise | 2023-02-03 4:33 pm | N/A N/A | Neoleukin Therapeutics Inc. | NLTX | Smith Sean Michael Principal Accounting Officer | 12,500 | $0 | 28,460 (Direct) | View |
| 2023-02-01 Exercise | 2023-02-03 4:32 pm | N/A N/A | Neoleukin Therapeutics Inc. | NLTX | Patel Priti Chief Medical Officer | 35,000 | $0 | 66,082 (Direct) | View |
| 2022-08-10 Exercise | 2022-08-12 5:24 pm | N/A N/A | Neoleukin Therapeutics Inc. | NLTX | Smith Sean Michael Principal Accounting Officer | 5,000 | $0 | 11,776 (Direct) | View |
| 2022-08-02 Option Award | 2022-08-04 4:43 pm | N/A 2032-08-01 | Neoleukin Therapeutics Inc. | NLTX | Walkey Carl Senior Vice President | 150,000 | $0 | 150,000 (Direct) | View |
| 2022-08-02 Option Award | 2022-08-04 4:41 pm | N/A 2032-08-01 | Neoleukin Therapeutics Inc. | NLTX | Smith Sean Michael Principal Accounting Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2022-08-02 Option Award | 2022-08-04 4:40 pm | N/A 2032-08-01 | Neoleukin Therapeutics Inc. | NLTX | Patel Priti Chief Medical Officer | 250,000 | $0 | 250,000 (Direct) | View |
| 2022-08-02 Option Award | 2022-08-04 4:38 pm | N/A 2032-08-01 | Neoleukin Therapeutics Inc. | NLTX | DRACHMAN JONATHAN G President and CEO | 350,000 | $0 | 350,000 (Direct) | View |
| 2022-08-02 Option Award | 2022-08-04 4:37 pm | N/A 2032-08-01 | Neoleukin Therapeutics Inc. | NLTX | Cochener Donna General Counsel, SVP Legal | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-05-12 Option Award | 2022-05-16 6:27 pm | N/A 2032-05-11 | Neoleukin Therapeutics Inc. | NLTX | SIMPSON TODD E Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-05-12 Option Award | 2022-05-16 6:26 pm | N/A 2032-05-11 | Neoleukin Therapeutics Inc. | NLTX | PALEKAR ROHAN Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-05-12 Option Award | 2022-05-16 6:24 pm | N/A 2032-05-11 | Neoleukin Therapeutics Inc. | NLTX | Noonberg Sarah B. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-05-12 Option Award | 2022-05-16 6:23 pm | N/A 2032-05-11 | Neoleukin Therapeutics Inc. | NLTX | Lavelle Erin Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-05-12 Option Award | 2022-05-16 6:22 pm | N/A 2032-05-11 | Neoleukin Therapeutics Inc. | NLTX | Babler Martin Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-05-12 Option Award | 2022-05-16 4:01 pm | N/A 2032-05-11 | Neoleukin Therapeutics Inc. | NLTX | BAKER BROS. ADVISORS LP 667 L.P. Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Director | 25,000 | $0 | 25,000 (Indirect) | View |
| 2022-04-30 Exercise | 2022-05-03 7:16 pm | N/A N/A | Neoleukin Therapeutics Inc. | NLTX | Patel Priti Chief Medical Officer | 10,000 | $0 | 16,462 (Direct) | View |
| 2022-03-14 Option Award | 2022-03-15 6:05 pm | N/A 2032-03-14 | Neoleukin Therapeutics Inc. | NLTX | Cochener Donna General Counsel, SVP Legal | 400,000 | $0 | 400,000 (Direct) | View |
| 2022-03-02 Option Award | 2022-03-04 6:12 pm | N/A 2032-03-01 | Neoleukin Therapeutics Inc. | NLTX | PALEKAR ROHAN Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-03-02 Option Award | 2022-03-03 4:39 pm | N/A 2032-03-01 | Neoleukin Therapeutics Inc. | NLTX | Smith Sean Michael Principal Accounting Officer | 80,000 | $0 | 80,000 (Direct) | View |
Ownership | 2022-03-03 4:38 pm | N/A N/A | Neoleukin Therapeutics Inc. | NLTX | Smith Sean Michael Principal Accounting Officer | 0 | $0 | 103,431 (Direct) | View |
| 2021-10-26 Ownership | 2022-02-14 7:54 pm | N/A N/A | Neoleukin Therapeutics Inc. | NLTX | DRACHMAN JONATHAN G President and CEO | 75,000 | $0 | 2,298,686 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-02 4:42 pm | N/A N/A | Neoleukin Therapeutics Inc. | NLTX | Walkey Carl Senior Vice President | 55,000 | $0 | 55,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-02 4:39 pm | N/A N/A | Neoleukin Therapeutics Inc. | NLTX | Patel Priti Chief Medical Officer | 70,000 | $0 | 70,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-02 4:36 pm | N/A N/A | Neoleukin Therapeutics Inc. | NLTX | Ho Robert Chief Financial Officer | 70,000 | $0 | 70,000 (Direct) | View |
| 2021-08-03 Option Award | 2021-08-05 4:29 pm | N/A 2031-08-03 | Neoleukin Therapeutics Inc. | NLTX | Walkey Carl Senior Vice President | 100,000 | $0 | 100,000 (Direct) | View |
| 2021-08-03 Option Award | 2021-08-05 4:25 pm | N/A 2031-08-03 | Neoleukin Therapeutics Inc. | NLTX | Vance Holly General Counsel | 100,000 | $0 | 100,000 (Direct) | View |
| 2021-08-03 Option Award | 2021-08-05 4:23 pm | N/A 2031-08-03 | Neoleukin Therapeutics Inc. | NLTX | Patel Priti Chief Medical Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2021-08-03 Option Award | 2021-08-05 4:14 pm | N/A 2031-08-03 | Neoleukin Therapeutics Inc. | NLTX | Ho Robert Chief Financial Officer | 190,000 | $0 | 190,000 (Direct) | View |
| 2021-08-03 Option Award | 2021-08-05 4:12 pm | N/A 2031-08-03 | Neoleukin Therapeutics Inc. | NLTX | DRACHMAN JONATHAN G President and CEO | 400,000 | $0 | 400,000 (Direct) | View |
| 2021-05-11 Option Award | 2021-05-13 5:39 pm | N/A 2031-05-10 | Neoleukin Therapeutics Inc. | NLTX | Williams Lewis T Director | 25,000 | $0 | 25,000 (Direct) | View |